HIMS & HERS HEALTH INC (HIMS) Stock Fundamental Analysis
USA - NYSE:HIMS - US4330001060 - Common Stock
45.46 USD
+1.4 (+3.18%)
46.3898 USD
+0.93 (+2.05%)
Overall HIMS gets a fundamental rating of 6 out of 10. We evaluated HIMS against 100 industry peers in the Health Care Providers & Services industry. HIMS has only an average score on both its financial health and profitability. HIMS is valued quite expensive, but it does show an excellent growth. With these ratings, HIMS could be worth investigating further for growth investing!.
1. Profitability
1.1 Basic Checks
HIMS had positive earnings in the past year.
HIMS had a positive operating cash flow in the past year.
HIMS had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: HIMS reported negative operating cash flow in multiple years.
1.2 Ratios
Looking at the Return On Assets, with a value of 10.31%, HIMS belongs to the top of the industry, outperforming 94.06% of the companies in the same industry.
HIMS has a better Return On Equity (34.41%) than 96.04% of its industry peers.
Looking at the Return On Invested Capital, with a value of 6.74%, HIMS is in the better half of the industry, outperforming 66.34% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.31% | ||
| ROE | 34.41% | ||
| ROIC | 6.74% |
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
HIMS has a better Profit Margin (9.62%) than 92.08% of its industry peers.
HIMS has a better Operating Margin (6.80%) than 67.33% of its industry peers.
HIMS's Gross Margin of 76.20% is amongst the best of the industry. HIMS outperforms 89.11% of its industry peers.
HIMS's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.8% | ||
| PM (TTM) | 9.62% | ||
| GM | 76.2% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), HIMS is destroying value.
HIMS has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, HIMS has more shares outstanding
There is no outstanding debt for HIMS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
An Altman-Z score of 6.58 indicates that HIMS is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 6.58, HIMS belongs to the best of the industry, outperforming 90.10% of the companies in the same industry.
The Debt to FCF ratio of HIMS is 8.11, which is on the high side as it means it would take HIMS, 8.11 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of HIMS (8.11) is comparable to the rest of the industry.
A Debt/Equity ratio of 1.72 is on the high side and indicates that HIMS has dependencies on debt financing.
HIMS's Debt to Equity ratio of 1.72 is on the low side compared to the rest of the industry. HIMS is outperformed by 71.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.72 | ||
| Debt/FCF | 8.11 | ||
| Altman-Z | 6.58 |
ROIC/WACC0.74
WACC9.16%
2.3 Liquidity
HIMS has a Current Ratio of 4.98. This indicates that HIMS is financially healthy and has no problem in meeting its short term obligations.
HIMS has a better Current ratio (4.98) than 93.07% of its industry peers.
A Quick Ratio of 4.46 indicates that HIMS has no problem at all paying its short term obligations.
HIMS has a Quick ratio of 4.46. This is amongst the best in the industry. HIMS outperforms 92.08% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.98 | ||
| Quick Ratio | 4.46 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 900.00% over the past year.
HIMS shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 60.35% yearly.
Looking at the last year, HIMS shows a very strong growth in Revenue. The Revenue has grown by 88.69%.
HIMS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 75.77% yearly.
EPS 1Y (TTM)900%
EPS 3YN/A
EPS 5Y60.35%
EPS Q2Q%183.33%
Revenue 1Y (TTM)88.69%
Revenue growth 3Y75.77%
Revenue growth 5YN/A
Sales Q2Q%72.61%
3.2 Future
Based on estimates for the next years, HIMS will show a very strong growth in Earnings Per Share. The EPS will grow by 41.75% on average per year.
HIMS is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 21.25% yearly.
EPS Next Y11.74%
EPS Next 2Y22.49%
EPS Next 3Y23.28%
EPS Next 5Y41.75%
Revenue Next Year59.73%
Revenue Next 2Y38.1%
Revenue Next 3Y31.07%
Revenue Next 5Y21.25%
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 56.82, which means the current valuation is very expensive for HIMS.
The rest of the industry has a similar Price/Earnings ratio as HIMS.
HIMS is valuated expensively when we compare the Price/Earnings ratio to 26.11, which is the current average of the S&P500 Index.
HIMS is valuated quite expensively with a Price/Forward Earnings ratio of 56.11.
HIMS's Price/Forward Earnings ratio is in line with the industry average.
HIMS is valuated expensively when we compare the Price/Forward Earnings ratio to 22.55, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 56.83 | ||
| Fwd PE | 56.11 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, HIMS is valued a bit more expensive than 60.40% of the companies in the same industry.
HIMS's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 85.98 | ||
| EV/EBITDA | 60.7 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates HIMS does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of HIMS may justify a higher PE ratio.
A more expensive valuation may be justified as HIMS's earnings are expected to grow with 23.28% in the coming years.
PEG (NY)4.84
PEG (5Y)0.94
EPS Next 2Y22.49%
EPS Next 3Y23.28%
5. Dividend
5.1 Amount
HIMS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
45.46
+1.4 (+3.18%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners88.61%
Inst Owner Change-0.03%
Ins Owners10.28%
Ins Owner Change-2.45%
Market Cap10.27B
Revenue(TTM)2.01B
Net Income(TTM)193.60M
Analysts68
Price Target49.8 (9.55%)
Short Float %32.95%
Short Ratio2.39
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)36.23%
Min EPS beat(2)10.29%
Max EPS beat(2)62.17%
EPS beat(4)4
Avg EPS beat(4)185.99%
Min EPS beat(4)4.62%
Max EPS beat(4)666.87%
EPS beat(8)7
Avg EPS beat(8)152.2%
EPS beat(12)11
Avg EPS beat(12)111.23%
EPS beat(16)12
Avg EPS beat(16)74.99%
Revenue beat(2)1
Avg Revenue beat(2)1.79%
Min Revenue beat(2)-3.17%
Max Revenue beat(2)6.75%
Revenue beat(4)3
Avg Revenue beat(4)1.72%
Min Revenue beat(4)-3.17%
Max Revenue beat(4)6.75%
Revenue beat(8)6
Avg Revenue beat(8)1.23%
Revenue beat(12)9
Avg Revenue beat(12)2.03%
Revenue beat(16)13
Avg Revenue beat(16)3.23%
PT rev (1m)-3.07%
PT rev (3m)1.17%
EPS NQ rev (1m)-2.06%
EPS NQ rev (3m)-34.44%
EPS NY rev (1m)-2.22%
EPS NY rev (3m)-11.45%
Revenue NQ rev (1m)0.15%
Revenue NQ rev (3m)-0.44%
Revenue NY rev (1m)0.04%
Revenue NY rev (3m)-0.17%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 56.83 | ||
| Fwd PE | 56.11 | ||
| P/S | 5.1 | ||
| P/FCF | 85.98 | ||
| P/OCF | 39.27 | ||
| P/B | 18.26 | ||
| P/tB | 25.41 | ||
| EV/EBITDA | 60.7 |
EPS(TTM)0.8
EY1.76%
EPS(NY)0.81
Fwd EY1.78%
FCF(TTM)0.53
FCFY1.16%
OCF(TTM)1.16
OCFY2.55%
SpS8.91
BVpS2.49
TBVpS1.79
PEG (NY)4.84
PEG (5Y)0.94
Graham Number6.69
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.31% | ||
| ROE | 34.41% | ||
| ROCE | 8.53% | ||
| ROIC | 6.74% | ||
| ROICexc | 23.47% | ||
| ROICexgc | 35.76% | ||
| OM | 6.8% | ||
| PM (TTM) | 9.62% | ||
| GM | 76.2% | ||
| FCFM | 5.94% |
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
F-Score6
Asset Turnover1.07
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.72 | ||
| Debt/FCF | 8.11 | ||
| Debt/EBITDA | 5.84 | ||
| Cap/Depr | 486.96% | ||
| Cap/Sales | 7.06% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 157.56% | ||
| Profit Quality | 61.73% | ||
| Current Ratio | 4.98 | ||
| Quick Ratio | 4.46 | ||
| Altman-Z | 6.58 |
F-Score6
WACC9.16%
ROIC/WACC0.74
Cap/Depr(3y)228.03%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.66%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)900%
EPS 3YN/A
EPS 5Y60.35%
EPS Q2Q%183.33%
EPS Next Y11.74%
EPS Next 2Y22.49%
EPS Next 3Y23.28%
EPS Next 5Y41.75%
Revenue 1Y (TTM)88.69%
Revenue growth 3Y75.77%
Revenue growth 5YN/A
Sales Q2Q%72.61%
Revenue Next Year59.73%
Revenue Next 2Y38.1%
Revenue Next 3Y31.07%
Revenue Next 5Y21.25%
EBIT growth 1Y821.91%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year358.46%
EBIT Next 3Y94.49%
EBIT Next 5Y60%
FCF growth 1Y927.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y922.97%
OCF growth 3YN/A
OCF growth 5YN/A
HIMS & HERS HEALTH INC / HIMS FAQ
What is the ChartMill fundamental rating of HIMS & HERS HEALTH INC (HIMS) stock?
ChartMill assigns a fundamental rating of 6 / 10 to HIMS.
What is the valuation status for HIMS stock?
ChartMill assigns a valuation rating of 2 / 10 to HIMS & HERS HEALTH INC (HIMS). This can be considered as Overvalued.
What is the profitability of HIMS stock?
HIMS & HERS HEALTH INC (HIMS) has a profitability rating of 6 / 10.
What is the earnings growth outlook for HIMS & HERS HEALTH INC?
The Earnings per Share (EPS) of HIMS & HERS HEALTH INC (HIMS) is expected to grow by 11.74% in the next year.